Ready to get your patient started on therapy?
Once you have identified an appropriate patient for a RRMM bispecific therapy, these actions may help prepare your patients and care partners for the treatment journey.
To foster an efficient and seamless treatment experience for your patient and to help mitigate potential treatment issues, determine your patient’s care plan, including dosing schedules, site(s) of administration, and prophylaxis procedures.
Topics may include:
- Therapy, including how the bispecific therapy for RRMM works, clinical trial results, step-up and treatment dosing, potential side effects and complications, dosing schedule, and care plan
- Care partner training, including monitoring for signs and symptoms of potential side effects and what to do in case of an emergency
- Logistical support, such as transportation, lodging, and meals
- Financial considerations, including estimated cost of therapy (accounting for insurance coverage), care partner support, visiting nurse services, and loss of work
Consider developing an informational packet for patients and care partners that includes the names of relevant team members, their roles and responsibilities, important phone numbers, who to contact at different times of the day, when to reach out to report symptoms, and when/where to go if they require hospitalization.
You may download the resource below to help educate your patients and their care partners:
Patient Bispecifics Teaching ToolThese programs can support your patient through their treatment journey by offering access assistance, affordability resources, and more. While each program varies, patients may receive customized support throughout their unique treatment journey. Additional details regarding patient support programs can be found in the J&J Resource Library.
Video Resource: Patient & Care Partner Team Readiness
View Part 3 of our national broadcast, led by Dr. Brooke Peters, PharmD, BCOP, and the Clinical Pharmacy Services Manager of Pharmacy Operations at the American Oncology Network, as she shares insights on key considerations for operationalizing bispecific therapies in patients with RRMM.
This video reviews important considerations that include:
- Logistical preparedness, such as travel, transportation, and access and affordability
- Care partner support, including the essential role they play in helping to monitor a patient on bispecific therapy
- Educating patients and care partners on treatment expectations
Need more?
Access the RRMM bispecifics Resource Library from Johnson & Johnson for tools to support your operational readiness.
Learn more about the bispecific antibody therapies for RRMM from Johnson & Johnson.
Learn moreHave additional questions about the operational process of treating RRMM with bispecifics?
Learn more